NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

PLoS Genetics

Volumn 9, Issue 6, 2013, Pages

  Kostadinov, Rumen L ^a,b,c   Kuhner, Mary K ^d   Li, Xiaohong ^e   Sanchez, Carissa A ^e   Galipeau, Patricia C ^e   Paulson, Thomas G ^e   Sather, Cassandra L ^e   Srivastava, Amitabh ^f   Odze, Robert D ^f   Blount, Patricia L ^e   Vaughan, Thomas L ^e   Reid, Brian J ^d,e   Maley, Carlo C ^a,b,g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CLINICAL ARTICLE; CLONAL EVOLUTION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; PHYLOGENY; REGULATORY MECHANISM; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BARRETT ESOPHAGUS; BIOPSY; CLONAL EVOLUTION; DISEASE PROGRESSION; FEMALE; GENOMIC INSTABILITY; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84879641253     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003553     Document Type: Article

References (50)

1. Nowell PC, (1976) The clonal evolution of tumor cell populations. Science 194: 23-28.
2. Merlo LMFF, Pepper JW, Reid BJ, Maley CC, (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
3. Greaves M, Maley CC, (2012) Clonal evolution in cancer. Nature 481: 306-313.
4. Li X, Blount PL, Vaughan TL, Reid BJ, (2011) Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view. PLoS computational biology 7: e1001087.
5. Leedham SJ, Preston SL, McDonald SAC, Elia G, Bhandari P, et al. (2008) Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 57: 1041-1048.
6. Reid BJ, Li X, Galipeau PC, Vaughan TL, (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nature reviews Cancer 10: 87-101.
7. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ, (2007) Meta analysis: Cancer risk in Barrett's oesophagus. Alimentary Pharmacology & Therapeutics 26: 1465-1477.
8. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P, (2011) Incidence of Adenocarcinoma among Patients with Barrett's Esophagus. New England Journal of Medicine 365: 1375-1383.
9. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK, (2010) History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 138: 854-869.
10. Boveri T (1914) Zur Frage der Entstehung maligner Tumoren. Jena: Gustav Fischer.
11. Lengauer C, Kinzler KW, Vogelstein B, (1998) Genetic instabilities in human cancers. Nature 396: 643-649.
12. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C, (2003) The significance of unstable chromosomes in colorectal cancer. Nature reviews Cancer 3: 695-701.
13. Hartwell L, (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546.
14. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
15. Tao Y, Ruan J, Yeh S-H, Lu X, Wang Y, et al. (2011) Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proceedings of the National Academy of Sciences of the United States of America 108: 12042-12047.
16. Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, et al. (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proceedings of the National Academy of Sciences of the United States of America 105: 13081-13086.
17. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England journal of medicine 366: 883-892.
18. Anderson K, Lutz C, Van Delft FW, Bateman CM, Guo Y, et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356-361.
19. Jones S, Chen W-D, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America 105: 4283-4288.
20. Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE, (1988) Progression to cancer in Barrett's esophagus is associated with genomic instability. Laboratory investigation; a journal of technical methods and pathology 60: 65-71.
21. Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, et al. (2008) Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer prevention research (Philadelphia, Pa) 1: 413-423.
22. Paulson TG, Maley CC, Li X, Li H, Sanchez CA, et al. (2009) Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research 15: 3305-3314.
23. Lai LA, Kostadinov R, Barrett MT, Peiffer DA, Pokholok D, et al. (2010) Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus. Molecular cancer research 8: 1084-1094.
24. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, et al. (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377: 31-41.
25. Corley DA, Kerlikowske K, Verma R, Buffler P, (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124: 47-56.
26. Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, et al. (2009) Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. British journal of cancer 100: 551-557.
27. Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, et al. (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. The Lancet Oncology 6: 945-952.
28. Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, et al. (2011) Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis. Gastroenterology.
29. Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, et al. (2007) NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS medicine 4: e67.
30. Drummond AJ, Nicholls GK, Rodrigo AG, Solomon W, (2002) Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 161: 1307-1320.
31. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC evolutionary biology 7: 214.
32. Gould SJ, Eldredge N, (1993) Punctuated equilibrium comes of age. Nature 366: 223-227.
33. Bak P, Boettcher S, (1997) Self-organized criticality and punctuated equilibria. Physica D: Nonlinear Phenomena 107: 143-150.
34. Van Nimwegen E, Crutchfield JP, Huynen M, (1999) Neutral evolution of mutational robustness. Proceedings of the National Academy of Sciences 96: 9716-9720.
35. Huynen MA, Stadler PF, Fontana W, (1996) Smoothness within ruggedness: the role of neutrality in adaptation. Proceedings of the National Academy of Sciences of the United States of America 93: 397-401.
36. Reid BJ, Kostadinov R, Maley CC, (2011) New Strategies in Barrett's Esophagus: Integrating clonal evolutionary theory with clinical management. Clinical cancer research: an official journal of the American Association for Cancer Research 17: 3512-3519.
37. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature pp. 1-6.
38. Hou Y, Song L, Zhu P, Zhang B, Tao Y, et al. (2012) Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148: 873-885.
39. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, et al. (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105: 40-50.
40. Farrow D, Vaughan T, Hansten P, Stanford J, Risch H, et al. (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7: 97-102.
41. Cheng H, Bjerknes M, Amar J, (1984) Methods for the determination of epithelial cell kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens. Gastroenterology 86: 78-85.
42. Ben-Yaacov E, Eldar YC, (2008) A fast and flexible method for the segmentation of aCGH data. Bioinformatics (Oxford, England) 24: i139-45.
43. Hupé P, Stransky N, Thiery J-P, Radvanyi F, Barillot E, (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics (Oxford, England) 20: 3413-3422.
44. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nature genetics 39: 906-913.
45. Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
46. Felsenstein J, (1981) Evolutionary trees from DNA sequences: a maximum likelihood approach. Journal of molecular evolution 17: 368-376.
47. Swofford DL (2002) PAUP*.Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts.
48. Mooers A, Heard S, (1997) Inferring Evolutionary Process from Phylogenetic Tree Shape. The Quarterly Review of Biology 72: 31-54.
49. Bortolussi N, Durand E, Blum M, François O, (2006) apTreeshape: statistical analysis of phylogenetic tree shape. Bioinformatics (Oxford, England) 22: 363-364.
50. Drewes A, Pedersen J, Liu W, Arendt-Nielsen L, Gregersen H, (2003) Controlled mechanical distension of the human oesophagus: sensory and biomechanical findings. Scandinavian journal of gastroenterology 38: 27-35.